🟢 Neuronetics is trading 6.60% up in pre-market after B. Riley initiated Buy coverage

Neuronetics is trading 6.60% up at $3.23 after B. Riley initiated Buy coverage with a $5.00 price target on September 11, 2026.

• The analyst cited Greenbrook’s growth potential, operating leverage, and Neuronetics’ repositioning as an interventional-psychiatry platform.
• Broader U.S. futures are lower on September 14, 2026, suggesting the move is not primarily market-driven.